Targeted therapies and survival: what we can learn from studies in advanced renal cell carcinoma.
Giuseppe
G
Procopio
Elena
E
Verzoni
Filippo
F
de Braud
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000378:metabolism / Q000401:mortality*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000401:mortality*; D058990:Molecular Targeted Therapy; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011379:Prognosis; D015996:Survival Rate
D000970:Antineoplastic Agents; D009363:Neoplasm Proteins